AUTL
Autolus Therapeutics
$1.63
+$0.08 (+5.16%)Oct 28, 2026
Key metrics
The numbers that frame AUTL today
- Market cap
- $433.84M
- Gross margin
- 15.7%
- EV / Sales
- 5.4
- ROIC
- -33.7%
- Div yield
- 0%
- Debt / equity
- 4.9
- 52wk Low
- $1.18
- 52wk High
- $2.58
Growth
Revenue and earnings trend for AUTL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AUTL
Is Autolus Therapeutics a good buy?
Hold. Autolus Therapeutics has excellent momentum, but weak quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Autolus Therapeutics is selling at a very high price.
What is the market capitalization of AUTL?
Autolus Therapeutics's market capitalization is $433.84M.
What is the 52-week high for AUTL stock?
The 52-week high for Autolus Therapeutics is $2.58. The current close of $1.63 is 36.8% below that high.
What is the 52-week low for AUTL stock?
The 52-week low for Autolus Therapeutics is $1.18. The current close of $1.63 is 38.7% above that low.
Does AUTL stock pay dividends?
Autolus Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AUTL?
Autolus Therapeutics's Debt / Equity ratio is 4.92.